MedTrace Logo

Transcriptomic and Biochemical Changes During a Migraine Attack

NCT02468622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-12-16

No results posted yet for this study

Summary

Despite the fact that migraine is a common disorder, the pathogenesis is still not fully elucidated. Studying transcriptomic and biochemical changes during induced and spontaneous migraine-attacks will enhance our understanding and may point to new targets for drug development.

Conditions

Interventions

OTHER

Blood samples

There is no intervention, but we will take blood samples during a spontaneous migraine attack

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Emma Katrine Hansen, Doctor · Danish Headache Center

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02468622 on ClinicalTrials.gov